SUMMARY Monoclonal antibodies raised by synthetic peptide immunisation were used to determine the distribution of the protein product of the c-myc gene by immunocytochemical staining of archival wax embedded material from patients with familial adenomatous polyposis. Polyps from 18 cases of familial adenomatous polyposis, 10 of whom had developed malignant change, and 30 normal control colonic biopsy specimens were examined. A consistent staining pattern was observed in normal mucosa; nuclear staining in the basal proliferative zone; mixed nuclear and cytoplasmic staining in the maturation zone; and cytoplasmic localisation in the surface mature zone. In contrast, the polyps and carcinomata showed a mixed pattern of cytoplasmic and nuclear localisation in the basal proliferative zone with nuclear persistence throughout the crypts to the surface mature zone. This abnormal distribution of the c-myc oncogene product may have a role in the evolution of polyps and their subsequent malignant transformation into familial adenomatous polyposis.
Familial adenomatous polyposis, also known as polyposis coli or familial polyposis, is inherited by an autosomal dominant gene.1 Numerous adenomatous polyps develop throughout the large intestine and unless treated by radical surgery the subsequent development of colonic carcinoma is inevitable. 2 3 The development of familial adenomatous polyposis is consistent with the multistep theory of carcinogenesis. 4 The essential first step is an inherited genetic defect leading to multiple polyps, following which malignant transformation takes place in some of the polyps. Little is known, however, about the nature of the gene defect or the molecular events entailed in the transformation of the colonic mucosa to adenomatous polyps and then to carcinoma. DNA synthesis occurs only in the lower portions of the crypts of Lieberkuhn in normal colonic mucosa,5 but studies in patients with familial adenomatous polyposis have shown that synthesis of DNA continues throughout the crypt and even in some areas of histologically normal tissues remote from the adenoma.6
An increasing body of evidence suggests that deregAccepted for publication 2 June 1987 ulation of cellular proto-oncogenes (c-onc), some of which have DNA sequence homology with trans- 7 8 forming RNA tumour were included in the study. Of these 18 patients, there were eight men and 10 women whose age range was 22-77 years at time of surgery. Ten of the patients (three men and seven women, age range 22-74) had evidence of colonic malignant disease) at the time of operation. After surgery the resected specimens were fixed in 10% buffered formalin and representative sections were wax embedded and material not used was stored in the archives of the department of pathology, Addenbrooke's Hospital.
Thirty normal colonoscopic or sigmoidoscopic biopsy specimens were taken from patients attending the gastroenterology clinic for investigation of bowel symptoms, including irritable bowel syndrome. These were prepared identically and used as control material.
ANTIBODIES AGAINST THE C-MYC PROTEIN
Full details for the production and characterisation of the antibodies are given elsewhere. 42 Briefly, the DNA base sequence of the cloned gene was used to determine the amino acid structure of the protein. Synthetic peptides were constructed to regions predicted to be hydrophilic and hence likely to be exposed on the surface of the complete molecule. Mice were immunised with the peptides to produce a number of monoclonal antibodies which immunoprecipitate a 62000 dalton protein identifiable with the c-myc product.42 One antibody, MYC 1-6E10, was raised to the 18 amino acid sequence (D-peptide) from residues 171-188. The second, MYC-CT14, was raised to a 32 amino acid peptide (G-peptide) corresponding to the carboxy terminus of p62C-myc (residues 408-439).
IMMUNOHISTOLOGY
Sections of 4 pm were cut from normal colonic biopsy specimens and from at least two separate polyps from each case of familial adenomatous polyposis. In the 10 cases with colonic malignant disease a representative section was also cut from the adenocarcinoma. The sections were mounted on glass slides, dewaxed in xylene, and rehydrated in serial dilutions of alcohol. The sections were then covered in 3% hydrogen peroxide for 10 minutes and washed in 10% bovine serum albumin (BSA) in phosphate buffered saline (PBS) for 10 minutes. After draining excess buffer from the slides the MYC I-6E10 antibody was added to the sections for 45 minutes at a concentration of 4 pg ml/-1. MYC-CT14 was used in several duplicate 1275 sections of normal mucosa at a concentration of 100pg ml/-I. This antibody has been found to give fluorescence signals which were four-fold lower than those with MYC 1-6E10 in flow cytometric studies,4" hence a higher concentration was used. The slides were then washed in PBS for five minutes at room temperature and a peroxidase conjugated rabbit antimouse serum (Dakopatts P260) diluted 1/100 was added and incubated at 20°C for 30 minutes. The slides were then washed in PBS and the peroxidase label visualised by incubation in a solution of 0-5 mg ml/-1 diaminobenzidine tetrahydrochloride plus 0 03% w/v H202 for 10 minutes. The sections were then washed in running tap water and light Harris's haematoxylin staining was carried out. Negative controls were prepared as in previous studies by blocking the MYC I-6E10 antibody with the D-peptide used as the immunogen. 26 36-41 The binding of this antibody was not blocked by preincubation with the G-peptide corresponding to the carboxy terminus of the c-myc protein.
Each section was examined by two pathologists independently. The crypts were divided into three zones where zone A corresponded to the basal proliferative zone and zone C to the surface mature epithelium ( fig 1) . Zone B, the intermediate maturation zone, was between zones A and C.
The distribution and intensity of p62c-IYC within cells was graded according to whether the pattern of staining was exclusively nuclear (N), exclusively cytoplasmic (C), or mixed (M) (fig 2) . The intensity was graded as 0 no staining; + minimal staining; + + moderate staining; or + + + heavy staining. The staining characteristics were studied in normal mucosa, polyps, mucosa adjacent to polyps, and in adenocarcinomas. 
Results
All results were obtained with the MYC undaresan, Forgacs, Wight, Wilson, Evan, Watson always ideal, hence the zones were arbitrarily defined as zone A corresponding to the lamina propria immediately above the muscularis mucosa and zone C as the surface epithelium which was often ulcerated in the carcinomas. The "intermediate" zone B was between zones A and C. The consistency of staining patterns, including both the intensity and subcellular location, were more variable than seen in the normal mucosa.
ADENOMATOUS POLYPS
In contrast to the normal controls, in 27 of 36 polyps from 18 cases nuclear staining was retained in the surface epithelium (zone C). In nine of these 27 polyps there was mixed nuclear and cytoplasmic staining. At the base of the crypts (zone A) normal nuclear staining was seen in all but three polyps. Of these 33 polyps, mixed cytoplasmic and nuclear staining was present in 12. The mucosa adjacent to the polyps was essentially the same as that of normal controls. No staining was seen in the normal mucosa adjacent to polyps in three separate cases (table 1, figs 3b, 4b, and 4c) 14 17 18 CARCINOMAS As in the polyps, and again contrasting with controls, there was nuclear staining of the malignant surface epithelium (zone C) in all but one of the 10 cases. Six of these nine cases were accompanied by cytoplasmic staining. In contrast to the controls, there was cytoplasmic staining in the proliferative zone (zone A) in eight of 10 cases. This was accompanied by nuclear staining in four of these eight. Nuclear staining resembling that seen in controls was seen in two cases in In contrast, the distribution of oncoprotein was quite different in adenoma and carcinoma, although the staining patterns were less consistent than in the normal mucosa. Of the 36 polyps from these 18 cases, 27 showed nuclear staining of the surface epithelium (zone C), while in the basal proliferative zone (zone A) there was some cytoplasmic staining in 14 of 36 polyps from 11 cases which was accompanied by nuclear staining. Cytoplasmic staining predominated in two polyps from two different patients. Nuclear staining of the surface epithelium (zone C) was seen in nine of 10 carcinomas, and eight of 10 showed cytoplasmic staining of cells in the basal proliferative zone. This abnormal staining pattern of carcinomas in zones A and C included mixed nuclear and cytoplasmic staining. Clearly, the staining patterns in polyps and carcinoma were different compared with those seen in normal mucosa. Subcellular fractionation in tissue culture cells has shown that p62C -IyC is predominantly nuclear associated. 43 Although neither the complete tertiary structure nor function of this protein is known, there is evidence that p62C-myc plays a part in cell cycle regulation and hence in proliferation control,24 -30 Thus the finding that p62c-mYc was predominantly nuclear associated in the normal crypt base is to be expected as this is the region containing stem cells which constantly repopulate the mucosa. There was, however, a completely consistent pattern in all normal biopsy specimens with increasing cytoplasmic and decreasing nuclear localisation with maturation. At the surface in normal mucosa the staining was exclusively located in the cytoplasm. Previous studies in colonic mucosa36 have also shown cytoplasmic staining using the MYC 1-6E10 antibody. Because of its known nuclear location in tissue culture cells,27 43 it was suggested that this could have been an artefact induced by the sampling and preparation procedures, as p62C-myc is very loosely bound in the nucleus. 43 The staining pattern characterising normal mucosa, however, was seen adjacent to the quite different pattern of adenomatous polyps in the same immunocytochemical preparation (fig 4) . Moreover, identical staining patterns were seen in normal mucosa with a second synthetic peptide induced antibody (MYC-CT14) which recognises a different epitope to that of MYC I-6E10. A very recently produced third antibody, pan-myc, which recognises a shared epitope on a number of the myc gene family of proteins was used in a very limited parallel study of only six sections (unpublished data). This also gave a staining pattern in normal mucosa identical with that of MYC 1-6E10 and MYC-CT14. These observations effectively exclude the possibility of artefact, and it is an intriguing possibility that the normal differentiation process may entail the active exclusion of this protein from the nucleus.
Oncogenes are normal constituents of the genome which play a part in the transmission and transduction of growth regulatory signals. The subversion of these normal processes in carcinogenesis is not yet understood, but mutation, gene amplification, promotor insertion, translocation and gene rearrangements resulting in inappropriate expression have all been implicated.47 Furthermore, several consistent chromosome abnormalities entailing oncogenes are associated with cancer. 48 The Philadelphia (Ph) chromosome49 is a common finding in chronic myeloid leukaemia and results from a 9:22 translocation. The c-abl oncogene is located near the breakpoint. The c-myc gene undergoes translocation from chromosome 8 to 14 in Burkitt's lymphoma with possible activation mediated at the immunoglobulin locus. 35 Oncogenes, which do not have viral homologues, have now been found close to known breakpoints associated with a number of malignant diseases.8 50 Malignant transformation of polyps in patients with familial polyposis is inevitable,3 and the disease is undoubtedly inherited where genetic factors have been postulated,244 although specific chromosomal lesions have not been observed. There is considerable individual variation in the age at which the florid malignant phenotype develops, however, and a number of specific genetic lesions occurring randomly in time within a susceptible genome may be responsible. Evidence for multiple functional genetic abnormalities in malignant transformation is forthcoming from both experimental45 and clinical data. A study on 54 patients with a range of 20 different malignant tumours has shown that more than one cellular oncogene was transcriptionally active.'4 Furthermore, in most of the 14 patients in whom it was possible to study both normal and malignant tissue from the same organ there was increased transcriptional activity of oncogenes in the malignant tissue. Other studies have shown that ras genes are overexpressed in colonic polyps and carcinoma,'5 and abnormalities of the myc gene family have been reported in several human malignant diseases,9-11 16 including colonic carcinoma. 46 The results of this immunocytochemical study are very interesting in this context as they have shown an abnormal subcellular distribution of p62C -MYC associated with both the known pre- 
